Abbott Laboratories (ABT) net income: $6.5B
Abbott Laboratories reported a net income of $6.5B for the year ended Dec 31, 2025, down 51.3% from $13.4B a year earlier.
From Abbott Laboratories's filings with the SEC · Read the filing · ABT stock page
Abbott Laboratories net income by year
#72 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $6.5B | -51% |
| Dec 31, 2024 | $13.4B | +134% |
| Dec 31, 2023 | $5.7B | -17% |
| Dec 31, 2022 | $6.9B | -2% |
| Dec 31, 2021 | $7.1B | – |
Net income of similar companies
Companies in the same industry as Abbott Laboratories, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Pfizer | $7.8B | Dec 31, 2025 |
| Bristol Myers Squibb | $7.1B | Dec 31, 2025 |
| Abbott Laboratories | $6.5B | Dec 31, 2025 |
| Regeneron Pharmaceuticals | $4.5B | Dec 31, 2025 |
| AbbVie | $4.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $4B | Dec 31, 2025 |
| Zoetis | $2.7B | Dec 31, 2025 |
Questions and answers
What is Abbott Laboratories's net income?
Abbott Laboratories reported a net income of $6.5B for the year ended Dec 31, 2025, down 51.3% from $13.4B a year earlier.
Numbers as reported in Abbott Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology